These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7908688)

  • 1. Did we focus on the most important issues in the use of growth factors and stem-cell transplantation?
    Gulati SC
    J Clin Oncol; 1994 Apr; 12(4):650-2. PubMed ID: 7908688
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
    Kanz L; Brugger W; Mertelsmann R
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):10-8. PubMed ID: 7528446
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
    Shpall EJ; Jones RB; Bearman SI; Franklin WA; Archer PG; Curiel T; Bitter M; Claman HN; Stemmer SM; Purdy M
    J Clin Oncol; 1994 Jan; 12(1):28-36. PubMed ID: 7505806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent high hopes held for colony stimulating factors.
    Vanchieri C
    J Natl Cancer Inst; 1993 Dec; 85(24):1982-3. PubMed ID: 8246281
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stem cell-colony stimulating factors].
    Urabe A; Kobayashi Y; Takaku F
    Gan No Rinsho; 1989 May; Spec No():287-93. PubMed ID: 2481048
    [No Abstract]   [Full Text] [Related]  

  • 6. Is blood or bone marrow better?
    Kessinger A
    Stem Cells; 1993 Jul; 11(4):290-5. PubMed ID: 8104616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduction in hematotoxicity of chemotherapy using reinfusion of hematopoietic stem cells].
    van Hoef ME
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):240-4. PubMed ID: 8094541
    [No Abstract]   [Full Text] [Related]  

  • 8. Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem-Cell Transplantation in Malignancies: Lyon, France, June 4-6, 1993.
    Coiffier B; Philip T; Burnett AK; Symann ML
    J Clin Oncol; 1994 Jan; 12(1):226-31. PubMed ID: 7903691
    [No Abstract]   [Full Text] [Related]  

  • 9. Is our current strategy in manipulating hemopoiesis in autologous transplantation correct?
    To LB
    Stem Cells; 1993 Jul; 11(4):283-9. PubMed ID: 8104615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a marrow stem-cell disorder with granulocyte colony-stimulating factor.
    Quesenberry PJ
    N Engl J Med; 1989 May; 320(20):1343-5. PubMed ID: 2469957
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic growth factors in bone marrow transplantation for hematologic malignancies.
    Lazarus HM
    Prog Clin Biol Res; 1990; 352():531-8. PubMed ID: 1698303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy].
    Gianni AM; Bregni M; Siena S; Tarella C
    Haematologica; 1989 Oct; 74(5 Suppl):511-26. PubMed ID: 2574136
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelosuppression and "conventional" chemotherapy: what price, what benefit?
    Canellos GP; Demetri GD
    J Clin Oncol; 1993 Jan; 11(1):1-2. PubMed ID: 8418220
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic growth factors in bone marrow transplantation: current and future directions.
    Aurer I; Ribas A; Gale RP
    Haematologica; 1991; 76(2):85-8. PubMed ID: 1682224
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow failure and hematopoietic growth factors.
    Douer D
    Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.
    Willemse PH; Boonstra H; de Vries EG
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):44-50. PubMed ID: 7528450
    [No Abstract]   [Full Text] [Related]  

  • 17. Criteria for use of filgrastim (granulocyte colony-stimulating factor).
    Clin Pharm; 1991 Dec; 10(12):950-2. PubMed ID: 1723034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone marrow protection by immunomodulators in antineoplastic chemotherapy].
    De Vita F; Della Vittoria Scarpati M; Diadema MR; Pilerci N; Catalano G
    G Ital Chemioter; 1991; 38(1-3):205-6. PubMed ID: 1365595
    [No Abstract]   [Full Text] [Related]  

  • 19. [Standards, options, and recommendations for the use of hematopoietic growth factors in oncology].
    Blay JY; Le Cesne A; Blanc-Vincent MP; Fervers B; Latour JF; Philip T
    Presse Med; 2000 Nov; 29(36):2004-8. PubMed ID: 11149085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New dimensions in the treatment of cancer?].
    Löwenberg B
    Ned Tijdschr Geneeskd; 1980 Mar; 124(10):337-9. PubMed ID: 6987542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.